Receptos LLC
(NASDAQ : RCPT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. -0.02%90.011.9%$1167.34m
JNJJohnson & Johnson -0.37%146.420.7%$1047.82m
BMYBristol-Myers Squibb Co. -0.19%59.701.0%$978.34m
MRKMerck & Co., Inc. -0.27%78.830.7%$821.20m
PFEPfizer Inc. -0.88%37.850.9%$817.24m
LLYEli Lilly & Co. 0.47%151.361.1%$454.18m
AZNAstraZeneca Plc 0.10%53.561.2%$264.87m
NVSNovartis AG 0.56%86.760.2%$155.40m
GSKGlaxoSmithKline Plc -0.33%41.410.2%$138.62m
NVONovo Nordisk A/S -0.43%64.680.1%$88.52m
SNYSanofi -0.31%48.530.2%$75.05m
RGENRepligen Corp. 0.98%130.477.1%$68.12m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.19%58.490.0%$44.19m
TPTXTurning Point Therapeutics, Inc. -3.77%65.990.0%$37.31m
ARCTArcturus Therapeutics Holdings, Inc. -0.86%36.430.0%$35.34m

Company Profile

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.